TEL-AML1 fusion transcript designates a favorable outcome with an intensified protocol in childhood acute lymphoblastic leukemia

Leukemia. 1999 Mar;13(3):481-3. doi: 10.1038/sj.leu.2401313.
No abstract available

Publication types

  • Clinical Trial
  • Letter

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Child
  • Child, Preschool
  • Core Binding Factor Alpha 2 Subunit
  • Disease-Free Survival
  • Female
  • Humans
  • Infant
  • Male
  • Neoplasm Proteins / genetics*
  • Oncogene Proteins, Fusion*
  • Phenotype
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma / drug therapy
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma / genetics*
  • Treatment Outcome

Substances

  • Core Binding Factor Alpha 2 Subunit
  • Neoplasm Proteins
  • Oncogene Proteins, Fusion
  • TEL-AML1 fusion protein